Beth Zelnick - Dec 12, 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Legal Officer
Signature: /s/ Beth Zelnick Kaufman
Stock symbol: CRMD
Transactions as of: Dec 12, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/14/2023, 04:05 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+50K		$0.00	50K	Dec 12, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRMD	Stock Option (Right to Buy Common Stock)	Award	$0	+200K		$0.00	200K	Dec 12, 2023	Common Stock	200K	$3.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These Restricted Stock Units were granted on 12/12/2023. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
F2	These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.